| |
| |
|
| Insider
Information: |
Bradbury Daniel |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
232,105 |
|
|
Indirect Shares
|
3,161,475 |
|
|
| Direct
Value |
$2,473,786 |
|
|
|
Indirect Value
|
$4,496,779 |
|
|
| Total
Shares |
3,393,580 |
|
|
| Total
Value |
$6,970,565 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amylin Pharmaceuticals Inc |
AMLN |
President & Chief Exec... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
Director |
2006-05-09 |
35,714 |
|
0 |
Premium* |
|
|
Illumina Inc |
ILMN |
Director |
2017-05-25 |
15,324 |
2008-05-16 |
0 |
Premium* |
|
|
Corcept Therapeutics Inc |
CORT |
Director |
2012-11-21 |
0 |
2019-02-07 |
130,575 |
Premium* |
|
|
Geron Corporation |
GERN |
Director |
2014-05-09 |
142,776 |
2019-03-29 |
51,323 |
Premium* |
|
|
Equillium Inc |
EQ |
Chief Executive Office... |
2018-10-16 |
0 |
2018-10-16 |
2,969,596 |
Premium* |
|
|
Castle Biosciences Inc |
CSTL |
Director |
2024-05-25 |
13,291 |
2024-05-06 |
9,981 |
Premium* |
|
|
Nuvation Bio Ord Shs Class A |
NUVB |
Director |
2021-02-10 |
25,000 |
2021-02-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
424 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 12 of 17
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2021-09-08 |
4 |
AS |
$75.88 |
$382,332 |
I/I |
(5,000) |
146,554 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2021-09-09 |
4 |
AS |
$76.14 |
$383,166 |
I/I |
(5,000) |
145,304 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2021-09-21 |
4 |
AS |
$73.82 |
$369,726 |
I/I |
(5,000) |
144,054 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2021-09-22 |
4 |
AS |
$73.90 |
$373,495 |
I/I |
(5,000) |
142,804 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2021-10-04 |
4 |
AS |
$60.23 |
$304,631 |
I/I |
(5,000) |
141,554 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2021-10-05 |
4 |
AS |
$62.04 |
$312,714 |
I/I |
(5,000) |
140,304 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2021-10-21 |
4 |
AS |
$62.06 |
$314,706 |
I/I |
(5,000) |
139,054 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2021-10-22 |
4 |
AS |
$62.51 |
$313,775 |
I/I |
(5,000) |
137,804 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2024-01-05 |
4 |
AS |
$20.36 |
$103,836 |
I/I |
(5,100) |
41,849 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-02-02 |
4 |
AS |
$28.55 |
$148,108 |
I/I |
(5,174) |
92,805 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
• – – |
2004-08-27 |
4 |
D |
$19.88 |
$103,495 |
D/D |
(5,206) |
26,636 |
|
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-10-21 |
4 |
AS |
$47.39 |
$255,648 |
I/I |
(5,250) |
786,578 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2021-11-08 |
4 |
AS |
$60.72 |
$339,942 |
I/I |
(5,554) |
135,305 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
• • – |
2009-03-13 |
5 |
GA |
$0.00 |
$0 |
I/I |
5,597 |
13,157 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
• • – |
2009-03-13 |
5 |
GD |
$0.00 |
$0 |
I/I |
5,597 |
35,118 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-11-20 |
4 |
AS |
$20.04 |
$115,330 |
I/I |
(5,755) |
63,910 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
• – – |
2004-02-27 |
4 |
OE |
$2.72 |
$16,061 |
I/I |
5,907 |
13,392 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Executive Vice President |
• – – |
2003-11-24 |
4 |
OE |
$7.13 |
$42,750 |
D/D |
6,000 |
16,194 |
|
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2008-10-21 |
4 |
AS |
$32.59 |
$195,835 |
D/D |
(6,000) |
2,000 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2008-10-21 |
4 |
OE |
$4.04 |
$24,210 |
D/D |
6,000 |
2,500 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2010-08-10 |
4 |
OE |
$4.04 |
$25,824 |
D/D |
6,400 |
2,037 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2010-08-10 |
4 |
AS |
$46.45 |
$297,376 |
D/D |
(6,400) |
1,937 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2010-09-10 |
4 |
OE |
$4.04 |
$25,824 |
D/D |
6,400 |
2,637 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2010-09-10 |
4 |
AS |
$44.33 |
$284,191 |
D/D |
(6,400) |
1,937 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2010-10-04 |
4 |
AS |
$49.42 |
$317,525 |
D/D |
(6,400) |
1,937 |
0 |
- |
|
424 Records found
|
|
Page 12 of 17 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
